These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2939001)

  • 1. [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].
    Bergmann JF; Rougier P; Liguory C; Zafrani ES; Métreau JM; Dhumeaux D
    Gastroenterol Clin Biol; 1986 Feb; 10(2):177-9. PubMed ID: 2939001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.
    Alazmi WM; McHenry L; Watkins JL; Fogel EL; Schmidt S; Sherman S; Lehman GL
    J Clin Gastroenterol; 2006 Apr; 40(4):353-7. PubMed ID: 16633109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common duct stricture associated with hepatic artery infusion of FUDR.
    Laughlin EH
    J Surg Oncol; 1986 Jan; 31(1):56-9. PubMed ID: 2935680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic sclerosing cholangitis following hepatic arterial chemotherapy infusion.
    Pien EH; Zeman RK; Benjamin SB; Barth KH; Jaffe MH; Choyke PL; Clark LR; Paushter DM
    Radiology; 1985 Aug; 156(2):329-30. PubMed ID: 3160062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.
    Shea WJ; Demas BE; Goldberg HI; Hohn DC; Ferrell LD; Kerlan RK
    AJR Am J Roentgenol; 1986 Apr; 146(4):717-21. PubMed ID: 2937274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM; Battifora H; Blayney DW; Cecchi G; Goldberg DA; Leong LA; Margolin KA; Terz JJ
    Ann Surg; 1985 Aug; 202(2):176-81. PubMed ID: 3160313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary sclerosis associated with hepatic artery infusion of floxuridine.
    Bolton JS; Bowen JC
    Surgery; 1986 Jan; 99(1):119-22. PubMed ID: 2934836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sclerosing cholangitis-induced biliary cyst formation: complication of hepatic artery infusion chemotherapy].
    Miyamoto S; Umekita N; Maeshiro T; Awane Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1684-6. PubMed ID: 7574792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile duct strictures associated with hepatic arterial infusion chemotherapy.
    Clark RA; Gallant TE
    Gastrointest Radiol; 1987; 12(2):148-51. PubMed ID: 2951292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complication due to arterial infusion chemotherapy for liver metastasis from colorectal cancer].
    Tsuji Y; Hamada H; Katsuki Y; Hashimoto M; Tomita I; Kon H; Sasaki R; Kawata S; Yasuda T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1838-42. PubMed ID: 9382546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Common bile duct fistula caused by hepatic arterial infusion chemotherapy].
    Ohori M; Umekita N; Maeshiro T; Miyamoto S; Yamada F; Awane Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1565-7. PubMed ID: 8854806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangitis complicating intraarterial chemotherapy in liver metastasis.
    Botet JF; Watson RC; Kemeny N; Daly JM; Yeh S
    Radiology; 1985 Aug; 156(2):335-7. PubMed ID: 3160063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ
    Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biliary and arterial obstructive processes in regional chemotherapy with FUDR].
    Schumacher KA; Roth J; Safi F; Friedrich JM; Weidenmaier WE
    Rofo; 1988 Nov; 149(5):476-9. PubMed ID: 2848277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary toxicity of 5-fluoro-2'-deoxyuridine. Intra-arterial versus portal venous routes of infusion.
    Andrews JC; Kuntsen C; Terio P; Priescorn D; Ensminger WD
    Invest Radiol; 1991 May; 26(5):461-4. PubMed ID: 1829068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
    J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
    Hohn D; Melnick J; Stagg R; Altman D; Friedman M; Ignoffo R; Ferrell L; Lewis B
    J Clin Oncol; 1985 Jan; 3(1):98-102. PubMed ID: 3155548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic biliary stent placement for bile duct stricture after hepatic artery infusion of 5-FUDR.
    Siegel JH; Ramsey WH
    J Clin Gastroenterol; 1986 Dec; 8(6):673-6. PubMed ID: 2949002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of hepatic arterial infusion chemotherapy.
    Pozniak MA; Babel SG; Trump DL
    Radiographics; 1991 Jan; 11(1):67-79. PubMed ID: 1825358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.